Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 54 entries
Sorted by: Best Match Show Resources per page
Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States.

ClinicoEconomics and outcomes research : CEOR

Knight T, Schaefer C, Chandran A, Zlateva G, Winkelmann A, Perrot S.
PMID: 23637545
Clinicoecon Outcomes Res. 2013 Apr 23;5:171-80. doi: 10.2147/CEOR.S41111. Print 2013.

BACKGROUND: Fibromyalgia (FM) is a chronic disorder characterized by widespread, persistent pain. Prospective and retrospective studies have demonstrated substantial health-care costs associated with FM in a number of countries. This study evaluated and compared health-resource use (HRU) and associated...

Cite
Knight T, Schaefer C, Chandran A, et al. Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States. Clinicoecon Outcomes Res. 2013;5:171-80doi: 10.2147/CEOR.S41111.
Knight, T., Schaefer, C., Chandran, A., Zlateva, G., Winkelmann, A., & Perrot, S. (2013). Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States. ClinicoEconomics and outcomes research : CEOR, 5171-80. https://doi.org/10.2147/CEOR.S41111
Knight, Tyler, et al. "Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States." ClinicoEconomics and outcomes research : CEOR vol. 5 (2013): 171-80. doi: https://doi.org/10.2147/CEOR.S41111
Knight T, Schaefer C, Chandran A, Zlateva G, Winkelmann A, Perrot S. Health-resource use and costs associated with fibromyalgia in France, Germany, and the United States. Clinicoecon Outcomes Res. 2013 Apr 23;5:171-80. doi: 10.2147/CEOR.S41111. Print 2013. PMID: 23637545; PMCID: PMC3637123.
Copy Download .nbib Format: NLM
Rapid reagent-less on-line H.

Talanta

Zlatev R, Stoytcheva M, Valdez B, Ramos R.
PMID: 28551151
Talanta. 2017 Aug 15;171:39-44. doi: 10.1016/j.talanta.2017.04.055. Epub 2017 Apr 26.

A simple, rapid, and reagent-less calorimetric method for H

Cite
Zlatev R, Stoytcheva M, Valdez B, et al. Rapid reagent-less on-line H. Talanta. 2017;171:39-44doi: 10.1016/j.talanta.2017.04.055.
Zlatev, R., Stoytcheva, M., Valdez, B., & Ramos, R. (2017). Rapid reagent-less on-line H. Talanta, 17139-44. https://doi.org/10.1016/j.talanta.2017.04.055
Zlatev, Roumen, et al. "Rapid reagent-less on-line H." Talanta vol. 171 (2017): 39-44. doi: https://doi.org/10.1016/j.talanta.2017.04.055
Zlatev R, Stoytcheva M, Valdez B, Ramos R. Rapid reagent-less on-line H. Talanta. 2017 Aug 15;171:39-44. doi: 10.1016/j.talanta.2017.04.055. Epub 2017 Apr 26. PMID: 28551151.
Copy Download .nbib Format: NLM
Delivery of size-controlled long-circulating polymersomes in solid tumours, visualized by quantum dots and optical imaging .

Biotechnology, biotechnological equipment

Bakalova R, Lazarova D, Nikolova B, Atanasova S, Zlateva G, Zhelev Z, Aoki I.
PMID: 26019630
Biotechnol Biotechnol Equip. 2015 Jan 02;29(1):175-180. doi: 10.1080/13102818.2014.984894. Epub 2014 Nov 26.

The present study was designed to investigate whether poly-ion complex hollow vesicles (polymersomes), based on chemically modified chitosan, are appropriate for passive tumour targeting in the context of their application as drug carriers. The experiments were performed on colon...

Cite
Bakalova R, Lazarova D, Nikolova B, et al. Delivery of size-controlled long-circulating polymersomes in solid tumours, visualized by quantum dots and optical imaging . Biotechnol Biotechnol Equip. 2014;29(1):175-180doi: 10.1080/13102818.2014.984894.
Bakalova, R., Lazarova, D., Nikolova, B., Atanasova, S., Zlateva, G., Zhelev, Z., & Aoki, I. (2015). Delivery of size-controlled long-circulating polymersomes in solid tumours, visualized by quantum dots and optical imaging . Biotechnology, biotechnological equipment, 29(1), 175-180. https://doi.org/10.1080/13102818.2014.984894
Bakalova, Rumiana, et al. "Delivery of size-controlled long-circulating polymersomes in solid tumours, visualized by quantum dots and optical imaging ." Biotechnology, biotechnological equipment vol. 29,1 (2015): 175-180. doi: https://doi.org/10.1080/13102818.2014.984894
Bakalova R, Lazarova D, Nikolova B, Atanasova S, Zlateva G, Zhelev Z, Aoki I. Delivery of size-controlled long-circulating polymersomes in solid tumours, visualized by quantum dots and optical imaging . Biotechnol Biotechnol Equip. 2015 Jan 02;29(1):175-180. doi: 10.1080/13102818.2014.984894. Epub 2014 Nov 26. PMID: 26019630; PMCID: PMC4434099.
Copy Download .nbib Format: NLM
[Pathologic and anatomic considerations on tuberculosis in children 2-14 years of age].

Suvremenna meditsina

MIKHAILOV G, ZLATEVA MKh.
PMID: 13146531
Suvr Med (Sofiia). 1953;4(11):51-8.

No abstract available.

Cite
MIKHAILOV G, ZLATEVA MKh. Patologoanatomichni prouchvaniia vurkhu tuberkulozata v detskata vuzrast (2-14 god.). [Pathologic and anatomic considerations on tuberculosis in children 2-14 years of age]. Suvr Med (Sofiia). 1953;4(11):51-8
MIKHAILOV, G., & ZLATEVA, M. K. h. (1953). Patologoanatomichni prouchvaniia vurkhu tuberkulozata v detskata vuzrast (2-14 god.). [Pathologic and anatomic considerations on tuberculosis in children 2-14 years of age]. Suvremenna meditsina, 4(11), 51-8.
MIKHAILOV, G, and ZLATEVA, M Kh. "Patologoanatomichni prouchvaniia vurkhu tuberkulozata v detskata vuzrast (2-14 god.)." [Pathologic and anatomic considerations on tuberculosis in children 2-14 years of age]. Suvremenna meditsina vol. 4,11 (1953): 51-8.
MIKHAILOV G, ZLATEVA MKh. Patologoanatomichni prouchvaniia vurkhu tuberkulozata v detskata vuzrast (2-14 god.). [Pathologic and anatomic considerations on tuberculosis in children 2-14 years of age]. Suvr Med (Sofiia). 1953;4(11):51-8. Undetermined. PMID: 13146531.
Copy Download .nbib Format: NLM
Joint assessment of intended and unintended effects of medications: an example using vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration.

Journal of ophthalmology

Levy AR, Szabo S, Briggs A, Pleil A, Davie A, Zlateva G, Javitt J.
PMID: 20339464
J Ophthalmol. 2009;2009:540431. doi: 10.1155/2009/540431. Epub 2010 Feb 16.

Objective. To estimate the net health benefits of pegaptanib and ranibizumab by considering the impact of visual acuity and unintended effects (cardiovascular and hemorrhagic events) on quality-of-life among persons with neovascular age-related macular degeneration. Methods. We designed a probabilistic...

Cite
Levy AR, Szabo S, Briggs A, et al. Joint assessment of intended and unintended effects of medications: an example using vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration. J Ophthalmol. 2010;2009:540431doi: 10.1155/2009/540431.
Levy, A. R., Szabo, S., Briggs, A., Pleil, A., Davie, A., Zlateva, G., & Javitt, J. (2009). Joint assessment of intended and unintended effects of medications: an example using vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration. Journal of ophthalmology, 2009540431. https://doi.org/10.1155/2009/540431
Levy, Adrian R, et al. "Joint assessment of intended and unintended effects of medications: an example using vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration." Journal of ophthalmology vol. 2009 (2009): 540431. doi: https://doi.org/10.1155/2009/540431
Levy AR, Szabo S, Briggs A, Pleil A, Davie A, Zlateva G, Javitt J. Joint assessment of intended and unintended effects of medications: an example using vascular endothelial growth factor inhibitors for neovascular age-related macular degeneration. J Ophthalmol. 2009;2009:540431. doi: 10.1155/2009/540431. Epub 2010 Feb 16. PMID: 20339464; PMCID: PMC2836847.
Copy Download .nbib Format: NLM
Simplifying Fibromyalgia Assessment: The VASFIQ Brief Symptom Scale.

Therapeutic advances in musculoskeletal disease

Boomershine CS, Emir B, Wang Y, Zlateva G.
PMID: 22870480
Ther Adv Musculoskelet Dis. 2011 Oct;3(5):215-26. doi: 10.1177/1759720X11416863.

OBJECTIVES: We tested the ability of the VASFIQ, a seven-item scale composed of Fibromyalgia Impact Questionnaire (FIQ) visual analog scales (VASs), to quantify fibromyalgia global disease severity and identify fibromyalgia patients with significant symptoms of fatigue, poor sleep, depression...

Cite
Boomershine CS, Emir B, Wang Y, et al. Simplifying Fibromyalgia Assessment: The VASFIQ Brief Symptom Scale. Ther Adv Musculoskelet Dis. 2011;3(5):215-26doi: 10.1177/1759720X11416863.
Boomershine, C. S., Emir, B., Wang, Y., & Zlateva, G. (2011). Simplifying Fibromyalgia Assessment: The VASFIQ Brief Symptom Scale. Therapeutic advances in musculoskeletal disease, 3(5), 215-26. https://doi.org/10.1177/1759720X11416863
Boomershine, Chad S, et al. "Simplifying Fibromyalgia Assessment: The VASFIQ Brief Symptom Scale." Therapeutic advances in musculoskeletal disease vol. 3,5 (2011): 215-26. doi: https://doi.org/10.1177/1759720X11416863
Boomershine CS, Emir B, Wang Y, Zlateva G. Simplifying Fibromyalgia Assessment: The VASFIQ Brief Symptom Scale. Ther Adv Musculoskelet Dis. 2011 Oct;3(5):215-26. doi: 10.1177/1759720X11416863. PMID: 22870480; PMCID: PMC3383533.
Copy Download .nbib Format: NLM
Effect of a Small Selective Inhibitor of C-Jun N-Terminal Kinase on the Inducible mRNA Expression of Interleukin-6 and Interleukin-18.

Open access Macedonian journal of medical sciences

Stanilova SA, Grigorov BG, Platikanova MS, Dobreva ZG.
PMID: 31456826
Open Access Maced J Med Sci. 2019 Jul 12;7(13):2062-2067. doi: 10.3889/oamjms.2019.567. eCollection 2019 Jul 15.

BACKGROUND: The expression of many inducible genes, involved in cell growth and differentiation as cytokine genes are regulated by receptor-activated intracellular signalling pathways, including the c-Jun N-terminal kinase (JNK) mitogen-activated protein kinase pathway.AIM: We examined the involvement of the...

Cite
Stanilova SA, Grigorov BG, Platikanova MS, et al. Effect of a Small Selective Inhibitor of C-Jun N-Terminal Kinase on the Inducible mRNA Expression of Interleukin-6 and Interleukin-18. Open Access Maced J Med Sci. 2019;7(13):2062-2067doi: 10.3889/oamjms.2019.567.
Stanilova, S. A., Grigorov, B. G., Platikanova, M. S., & Dobreva, Z. G. (2019). Effect of a Small Selective Inhibitor of C-Jun N-Terminal Kinase on the Inducible mRNA Expression of Interleukin-6 and Interleukin-18. Open access Macedonian journal of medical sciences, 7(13), 2062-2067. https://doi.org/10.3889/oamjms.2019.567
Stanilova, Spaska A, et al. "Effect of a Small Selective Inhibitor of C-Jun N-Terminal Kinase on the Inducible mRNA Expression of Interleukin-6 and Interleukin-18." Open access Macedonian journal of medical sciences vol. 7,13 (2019): 2062-2067. doi: https://doi.org/10.3889/oamjms.2019.567
Stanilova SA, Grigorov BG, Platikanova MS, Dobreva ZG. Effect of a Small Selective Inhibitor of C-Jun N-Terminal Kinase on the Inducible mRNA Expression of Interleukin-6 and Interleukin-18. Open Access Maced J Med Sci. 2019 Jul 12;7(13):2062-2067. doi: 10.3889/oamjms.2019.567. eCollection 2019 Jul 15. PMID: 31456826; PMCID: PMC6698100.
Copy Download .nbib Format: NLM
Cognitive Correlates of Hippocampal Atrophy and Ventricular Enlargement in Adults with or without Mild Cognitive Impairment.

Dementia and geriatric cognitive disorders extra

Goukasian N, Porat S, Blanken A, Avila D, Zlatev D, Hurtz S, Hwang KS, Pierce J, Joshi SH, Woo E, Apostolova LG.
PMID: 31572424
Dement Geriatr Cogn Dis Extra. 2019 Aug 13;9(2):281-293. doi: 10.1159/000490044. eCollection 2019.

We analyzed structural magnetic resonance imaging data from 58 cognitively normal and 101 mild cognitive impairment subjects. We used a general linear regression model to study the association between cognitive performance with hippocampal atrophy and ventricular enlargement using the...

Cite
Goukasian N, Porat S, Blanken A, et al. Cognitive Correlates of Hippocampal Atrophy and Ventricular Enlargement in Adults with or without Mild Cognitive Impairment. Dement Geriatr Cogn Dis Extra. 2019;9(2):281-293doi: 10.1159/000490044.
Goukasian, N., Porat, S., Blanken, A., Avila, D., Zlatev, D., Hurtz, S., Hwang, K. S., Pierce, J., Joshi, S. H., Woo, E., & Apostolova, L. G. (2019). Cognitive Correlates of Hippocampal Atrophy and Ventricular Enlargement in Adults with or without Mild Cognitive Impairment. Dementia and geriatric cognitive disorders extra, 9(2), 281-293. https://doi.org/10.1159/000490044
Goukasian, Naira, et al. "Cognitive Correlates of Hippocampal Atrophy and Ventricular Enlargement in Adults with or without Mild Cognitive Impairment." Dementia and geriatric cognitive disorders extra vol. 9,2 (2019): 281-293. doi: https://doi.org/10.1159/000490044
Goukasian N, Porat S, Blanken A, Avila D, Zlatev D, Hurtz S, Hwang KS, Pierce J, Joshi SH, Woo E, Apostolova LG. Cognitive Correlates of Hippocampal Atrophy and Ventricular Enlargement in Adults with or without Mild Cognitive Impairment. Dement Geriatr Cogn Dis Extra. 2019 Aug 13;9(2):281-293. doi: 10.1159/000490044. eCollection 2019. PMID: 31572424; PMCID: PMC6751474.
Copy Download .nbib Format: NLM
Effect of Alpha-tocopheryl Succinate on the Cytotoxicity of Anticancer Drugs Towards Leukemia Lymphocytes.

Anticancer research

Ivanova D, Zhelev Z, Zlateva G, Lazarova D, Yaneva Z, Panovska R, Aoki I, Bakalova R.
PMID: 34969764
Anticancer Res. 2022 Jan;42(1):547-554. doi: 10.21873/anticanres.15512.

BACKGROUND/AIM: This study analysed the effect of α-tocopheryl succinate (α-TS) on the redox-state of leukemia and normal lymphocytes, as well as their sensitization to fifteen anticancer drugs.MATERIALS AND METHODS: Cell viability was analyzed by trypan blue staining and automated...

Cite
Ivanova D, Zhelev Z, Zlateva G, et al. Effect of Alpha-tocopheryl Succinate on the Cytotoxicity of Anticancer Drugs Towards Leukemia Lymphocytes. Anticancer Res. 2022;42(1):547-554doi: 10.21873/anticanres.15512.
Ivanova, D., Zhelev, Z., Zlateva, G., Lazarova, D., Yaneva, Z., Panovska, R., Aoki, I., & Bakalova, R. (2022). Effect of Alpha-tocopheryl Succinate on the Cytotoxicity of Anticancer Drugs Towards Leukemia Lymphocytes. Anticancer research, 42(1), 547-554. https://doi.org/10.21873/anticanres.15512
Ivanova, Donika, et al. "Effect of Alpha-tocopheryl Succinate on the Cytotoxicity of Anticancer Drugs Towards Leukemia Lymphocytes." Anticancer research vol. 42,1 (2022): 547-554. doi: https://doi.org/10.21873/anticanres.15512
Ivanova D, Zhelev Z, Zlateva G, Lazarova D, Yaneva Z, Panovska R, Aoki I, Bakalova R. Effect of Alpha-tocopheryl Succinate on the Cytotoxicity of Anticancer Drugs Towards Leukemia Lymphocytes. Anticancer Res. 2022 Jan;42(1):547-554. doi: 10.21873/anticanres.15512. PMID: 34969764.
Copy Download .nbib Format: NLM
Pharmacological Strategy for Selective Targeting of Glioblastoma by Redox-active Combination Drug - Comparison With the Chemotherapeutic Standard-of-care Temozolomide.

Anticancer research

Sumiyoshi A, Shibata S, Zhelev Z, Miller T, Lazarova D, Zlateva G, Aoki I, Bakalova R.
PMID: 34848461
Anticancer Res. 2021 Dec;41(12):6067-6076. doi: 10.21873/anticanres.15426.

BACKGROUND/AIM: We describe a pharmacological strategy for selectively targeting glioblastoma using a redox-active combination drug menadione/ascorbate (M/A), compared to the chemotherapeutic standard-of-care temozolomide (TMZ).MATERIALS AND METHODS: Experiments were conducted on glioblastoma mice (GS9L cell transplants - intracranial model), treated...

Cite
Sumiyoshi A, Shibata S, Zhelev Z, et al. Pharmacological Strategy for Selective Targeting of Glioblastoma by Redox-active Combination Drug - Comparison With the Chemotherapeutic Standard-of-care Temozolomide. Anticancer Res. 2021;41(12):6067-6076doi: 10.21873/anticanres.15426.
Sumiyoshi, A., Shibata, S., Zhelev, Z., Miller, T., Lazarova, D., Zlateva, G., Aoki, I., & Bakalova, R. (2021). Pharmacological Strategy for Selective Targeting of Glioblastoma by Redox-active Combination Drug - Comparison With the Chemotherapeutic Standard-of-care Temozolomide. Anticancer research, 41(12), 6067-6076. https://doi.org/10.21873/anticanres.15426
Sumiyoshi, Akira, et al. "Pharmacological Strategy for Selective Targeting of Glioblastoma by Redox-active Combination Drug - Comparison With the Chemotherapeutic Standard-of-care Temozolomide." Anticancer research vol. 41,12 (2021): 6067-6076. doi: https://doi.org/10.21873/anticanres.15426
Sumiyoshi A, Shibata S, Zhelev Z, Miller T, Lazarova D, Zlateva G, Aoki I, Bakalova R. Pharmacological Strategy for Selective Targeting of Glioblastoma by Redox-active Combination Drug - Comparison With the Chemotherapeutic Standard-of-care Temozolomide. Anticancer Res. 2021 Dec;41(12):6067-6076. doi: 10.21873/anticanres.15426. PMID: 34848461.
Copy Download .nbib Format: NLM
Small circular interfering RNAs (sciRNAs) as a potent therapeutic platform for gene-silencing.

Nucleic acids research

Jahns H, Degaonkar R, Podbevsek P, Gupta S, Bisbe A, Aluri K, Szeto J, Kumar P, LeBlanc S, Racie T, Brown CR, Castoreno A, Guenther DC, Jadhav V, Maier MA, Plavec J, Egli M, Manoharan M, Zlatev I.
PMID: 34508350
Nucleic Acids Res. 2021 Oct 11;49(18):10250-10264. doi: 10.1093/nar/gkab724.

In order to achieve efficient therapeutic post-transcriptional gene-silencing mediated by the RNA interference (RNAi) pathway, small interfering RNAs (siRNAs) must be chemically modified. Several supra-RNA structures, with the potential to stabilize siRNAs metabolically have been evaluated for their ability...

Cite
Jahns H, Degaonkar R, Podbevsek P, et al. Small circular interfering RNAs (sciRNAs) as a potent therapeutic platform for gene-silencing. Nucleic Acids Res. 2021;49(18):10250-10264doi: 10.1093/nar/gkab724.
Jahns, H., Degaonkar, R., Podbevsek, P., Gupta, S., Bisbe, A., Aluri, K., Szeto, J., Kumar, P., LeBlanc, S., Racie, T., Brown, C. R., Castoreno, A., Guenther, D. C., Jadhav, V., Maier, M. A., Plavec, J., Egli, M., Manoharan, M., & Zlatev, I. (2021). Small circular interfering RNAs (sciRNAs) as a potent therapeutic platform for gene-silencing. Nucleic acids research, 49(18), 10250-10264. https://doi.org/10.1093/nar/gkab724
Jahns, Hartmut, et al. "Small circular interfering RNAs (sciRNAs) as a potent therapeutic platform for gene-silencing." Nucleic acids research vol. 49,18 (2021): 10250-10264. doi: https://doi.org/10.1093/nar/gkab724
Jahns H, Degaonkar R, Podbevsek P, Gupta S, Bisbe A, Aluri K, Szeto J, Kumar P, LeBlanc S, Racie T, Brown CR, Castoreno A, Guenther DC, Jadhav V, Maier MA, Plavec J, Egli M, Manoharan M, Zlatev I. Small circular interfering RNAs (sciRNAs) as a potent therapeutic platform for gene-silencing. Nucleic Acids Res. 2021 Oct 11;49(18):10250-10264. doi: 10.1093/nar/gkab724. PMID: 34508350; PMCID: PMC8501968.
Copy Download .nbib Format: NLM
Renoprotective Effects of Small Interfering RNA Targeting Liver Angiotensinogen in Experimental Chronic Kidney Disease.

Hypertension (Dallas, Tex. : 1979)

Bovée DM, Ren L, Uijl E, Clahsen-van Groningen MC, van Veghel R, Garrelds IM, Domenig O, Poglitsch M, Zlatev I, Kim JB, Huang S, Melton L, Lu X, Hoorn EJ, Foster D, Danser AHJ.
PMID: 33719507
Hypertension. 2021 May 05;77(5):1600-1612. doi: 10.1161/HYPERTENSIONAHA.120.16876. Epub 2021 Mar 15.

[Figure: see text].

Cite
Bovée DM, Ren L, Uijl E, et al. Renoprotective Effects of Small Interfering RNA Targeting Liver Angiotensinogen in Experimental Chronic Kidney Disease. Hypertension. 2021;77(5):1600-1612doi: 10.1161/HYPERTENSIONAHA.120.16876.
Bovée, D. M., Ren, L., Uijl, E., Clahsen-van Groningen, M. C., van Veghel, R., Garrelds, I. M., Domenig, O., Poglitsch, M., Zlatev, I., Kim, J. B., Huang, S., Melton, L., Lu, X., Hoorn, E. J., Foster, D., & Danser, A. H. J. (2021). Renoprotective Effects of Small Interfering RNA Targeting Liver Angiotensinogen in Experimental Chronic Kidney Disease. Hypertension (Dallas, Tex. : 1979), 77(5), 1600-1612. https://doi.org/10.1161/HYPERTENSIONAHA.120.16876
Bovée, Dominique M, et al. "Renoprotective Effects of Small Interfering RNA Targeting Liver Angiotensinogen in Experimental Chronic Kidney Disease." Hypertension (Dallas, Tex. : 1979) vol. 77,5 (2021): 1600-1612. doi: https://doi.org/10.1161/HYPERTENSIONAHA.120.16876
Bovée DM, Ren L, Uijl E, Clahsen-van Groningen MC, van Veghel R, Garrelds IM, Domenig O, Poglitsch M, Zlatev I, Kim JB, Huang S, Melton L, Lu X, Hoorn EJ, Foster D, Danser AHJ. Renoprotective Effects of Small Interfering RNA Targeting Liver Angiotensinogen in Experimental Chronic Kidney Disease. Hypertension. 2021 May 05;77(5):1600-1612. doi: 10.1161/HYPERTENSIONAHA.120.16876. Epub 2021 Mar 15. PMID: 33719507.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 54 entries